MK2: a novel molecular target for anti-inflammatory therapy

Author： Duraisamy Senthil   Bajpai Malini   Bughani Usha   Dastidar Sunanda G   Ray Abhijit   Chopra Puneet  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.8, 2008-08, pp. : 921-936

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Anti-inflammatory Interleukin-35 as an Emerging Target for Antiatherosclerotic Therapy

By  

Current Pharmaceutical Design, Vol. 21, Iss. 9, 2015-03 ,pp. : 1147-1151

Bentham Science Publishers

Access to resources Recommend Favorite

Novel anti-inflammatory therapy for Parkinson's disease

By Gao H.-M.   Liu B.   Zhang W.   Hong J.-S.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 8, 2003-08 ,pp. : 395-401

Elsevier

Access to resources Recommend Favorite

Melanocortin Receptor Type 3 as a Potential Target for Anti-Inflammatory Therapy

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-09 ,pp. : 311-315

Bentham Science Publishers

Access to resources Recommend Favorite

STAT1 as a New Molecular Target of Anti-Inflammatory Treatment

By  

Current Medicinal Chemistry, Vol. 12, Iss. 16, 2005-08 ,pp. : 1819-1828

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of the Novel Non-Peptidyl Low Molecular Weight Radical Scavenger IAC in Different Models of Inflammation: A New Perspective in Anti-Inflammatory Therapy

By  

Current Medicinal Chemistry, Vol. 17, Iss. 32, 2010-11 ,pp. : 3918-3924

Bentham Science Publishers

Access to resources Recommend Favorite